Abound Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Abound Wealth Management's AMGN Position: Q2 2026 in Review
Abound Wealth Management reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $34.9K and leaving 892 shares worth $323K. The position accounts for 0.06% of the portfolio, ranked #69.
Abound Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $350K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Abound Wealth Management held 892 shares of Amgen worth $323K as of Q2 2026.
- Abound Wealth Management sold 102 Amgen shares in Q2 2026, an estimated $34.9K.
- Amgen made up 0.06% of Abound Wealth Management's portfolio in Q2 2026, its #69 holding.
- Abound Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Abound Wealth Management's Amgen position peaked at $350K in Q1 2026.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.